Sign Out
Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see Pharmacology: Pharmacodynamics under Actions, Dosage & Administration and Precautions).
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
